- Home
- PSTX
as 11-21-2024 11:37am EST
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 360.4M | IPO Year: | 2020 |
| Target Price: | $15.00 | AVG Volume (30 days): | 538.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.87 - $4.27 | Next Earning Date: | 11-07-2024 |
| Revenue: | $150,858,000 | Revenue Growth: | 203.18% |
| Revenue Growth (this year): | 64.38% | Revenue Growth (next year): | -58.44% |
Latest Poseida Therapeutics Inc. News
PSTX Breaking Stock News: Dive into PSTX Ticker-Specific Updates for Smart Investing
PR Newswire
7 days ago
Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline
Zacks
9 days ago
Poseida Therapeutics, Inc. (PSTX) Is Up 24.70% in One Week: What You Should Know
PR Newswire
10 days ago
Poseida Therapeutics to Present at Two Upcoming Investor Conferences
Simply Wall St.
12 days ago
Poseida Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Zacks
14 days ago
Poseida Therapeutics, Inc. (PSTX) Q3 Earnings and Revenues Beat Estimates
PR Newswire
14 days ago
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024
PR Newswire
16 days ago
Poseida Therapeutics to Present Clinical and Preclinical Data on Investigational Allogeneic CAR-T Cell Therapies at SITC 2024 and ASH 2024
Simply Wall St.
17 days ago
Organogenesis Holdings And 2 Other US Penny Stocks To Watch
Compare PSTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PSTX Poseida Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.